Aqualyx vs CoolSculpting: Which Is More Suitable for Localised Fat Reduction?

Clinical guidance from Dr Nyla Raja MBChB (Hons), MRCGP (Dist), DFFP, DPDermatology - GMC No. 6057913

Dr Nyla Medispa offers both Aqualyx fat-dissolving injections and CoolSculpting for selected pockets of localised fat. Neither is automatically the better treatment. Aqualyx may be more suitable for a small, precisely defined area that can be appropriately treated with injections, while CoolSculpting may be more practical for a larger pinchable fat deposit where an applicator can sit correctly.

Both treatments are designed for body contouring rather than weight loss. The most appropriate option depends on the area, the amount and distribution of subcutaneous fat, skin quality, medical history, and the degree of improvement you hope to achieve.

Aqualyx and CoolSculpting work in different ways

Aqualyx is an injectable treatment. Its deoxycholate-based formulation is placed within suitable fatty tissue to disrupt treated fat cells, after which the body gradually clears the cellular material.

CoolSculpting is an applicator-based cryolipolysis treatment. It uses controlled cooling to target selected fat cells without injections or incisions. Changes develop gradually over subsequent weeks and months as the body processes the affected cells.

This difference matters in practice. An injectable treatment can be planned around a small, localised deposit, whereas cryolipolysis requires enough appropriately shaped, pinchable tissue for the applicator to fit securely. Neither treatment can address visceral fat inside the abdomen, and neither is intended to produce significant overall weight reduction.

When Aqualyx may be the more suitable option

Aqualyx may be considered when the concern is a relatively small and defined pocket of subcutaneous fat, such as selected fullness beneath the chin, around the knees, or in a limited body area. It can be useful where an external applicator would not sit appropriately, or where a more targeted injectable approach is clinically suitable.

However, injections are not necessarily the easier option simply because the treatment area is small. Aqualyx creates an inflammatory response in the treated tissue, so swelling, tenderness, redness, bruising, and temporary firmness can occur while the area settles. This can be particularly relevant for facial areas, where visible swelling may affect social plans.

A course may be required. Sessions are usually spaced apart to allow swelling to settle and for the response to the previous treatment to be assessed. More treatment is not automatically better; the aim is proportionate contour improvement rather than removing as much volume as possible.

When CoolSculpting may be the more suitable option

CoolSculpting may be more appropriate for a larger, pinchable bulge of subcutaneous fat on areas such as the abdomen, flanks, thighs, upper arms, or back. It is non-invasive, with no needles, and many patients can return to normal day-to-day activity after their appointment.

Applicator fit is central to suitability. The area needs to have sufficient, correctly positioned tissue for controlled cooling to be delivered safely and evenly. A visible abdominal contour, for example, may be caused by a combination of superficial fat, deeper visceral fat, loose skin, or muscle separation. Cooling superficial fat will not correct the other causes.

CoolSculpting results develop gradually. This can suit patients seeking a measured change rather than an immediate alteration, but it also means treatment should be planned well in advance of an event or holiday.

Skin laxity can change the treatment decision

Both Aqualyx and CoolSculpting reduce selected fat deposits; neither should be viewed as a skin-tightening treatment. If the skin has reduced elasticity, removing underlying fat may leave the skin unchanged or, in some cases, make laxity more apparent.

This is especially important beneath the chin and on the abdomen after weight change or pregnancy. Under-chin fullness may relate to fat, skin laxity, chin projection, jaw position, neck anatomy, or muscle structure. Similarly, an abdominal prominence may not be caused mainly by pinchable fat. An in-person assessment is therefore more useful than choosing a treatment from photographs alone.

Safety, downtime, and suitability considerations

Both treatments have predictable, temporary after-effects, but they are different. With Aqualyx, swelling and soreness are common while the treated tissue settles. With CoolSculpting, temporary redness, bruising, swelling, numbness, tingling, tenderness, or sensitivity can occur after treatment.

CoolSculpting also has a rare but important treatment-specific complication called paradoxical adipose hyperplasia, where the treated fatty area enlarges rather than reduces in the months after treatment. The FDA explains the potential risks of non-invasive body-contouring technologies, including this complication and why appropriate assessment matters.

CoolSculpting may not be appropriate for people with cryoglobulinaemia, cold agglutinin disease, or paroxysmal cold haemoglobinuria. Pregnancy, a known or suspected hernia near the proposed treatment area, recent surgery, cold sensitivity, and local skin or circulation concerns should also be discussed during assessment. Aqualyx should be deferred during pregnancy and breastfeeding, and may not be appropriate where infection, inflammation, relevant medical conditions, or other contraindications are identified.

For either treatment, severe, worsening, or prolonged symptoms should be assessed promptly by the treating clinic or another appropriate healthcare professional.

Regulatory language: what patients should know

CoolSculpting is described as FDA-cleared in the United States, but FDA clearance is a US regulatory term and should not be mistaken for MHRA approval in the UK. The MHRA regulates the medical-device market in Great Britain, and its guidance explains that device registration does not amount to MHRA endorsement or approval. You can read the current MHRA guidance on regulating medical devices in the UK for further context.

When comparing providers, it is reasonable to ask who will assess and carry out your treatment, how your anatomy and medical history will be considered, what product or device will be used, what recovery to expect, and how follow-up concerns are managed.

Which treatment is more suitable for you?

Aqualyx may be more suitable for a small, precisely targeted area of localised fat where an injectable approach is appropriate. CoolSculpting may be more suitable for a broader, pinchable fat deposit that can be treated effectively with an applicator and where avoiding injections is important.

The key point is that neither treatment is a substitute for weight management, neither treats visceral fat or significant loose skin, and neither can be selected safely on the basis of area alone. The best choice comes from identifying what is creating the contour concern, then selecting the most proportionate treatment for that anatomy and goal.